Jilin Jian Yisheng Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Jilin Jian Yisheng Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) has a cash flow conversion efficiency ratio of 0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥8.20 Million ≈ $1.20 Million USD) by net assets (CN¥2.32 Billion ≈ $340.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Jilin Jian Yisheng Pharmaceutical Co Ltd market cap and net worth for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of Jilin Jian Yisheng Pharmaceutical Co Ltd (2006–2025)
Cash flow conversion efficiency of Jilin Jian Yisheng Pharmaceutical Co Ltd from 2006 to 2025. This chart illustrates how Jilin Jian Yisheng Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Jilin Jian Yisheng Pharmaceutical Co Ltd share price for real-time trading data and today's change.
Jilin Jian Yisheng Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Jilin Jian Yisheng Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Jilin Jian Yisheng Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jilin Jian Yisheng Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Review Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
AIM Industrial Growth Freehold and Leasehold Real Estate Investment Trust
BK:AIMIRT
|
0.013x |
|
Youngtek Electronics
TWO:6261
|
0.041x |
|
Plum Acquisition Corp. IV Unit
NASDAQ:PLMKU
|
-0.001x |
|
Clearview Wealth Ltd
AU:CVW
|
-3.782x |
|
Sarawak Plantation Bhd
KLSE:5135
|
0.031x |
|
Bit Digital Inc
NASDAQ:BTBT
|
0.090x |
|
Beijing ZEHO Waterfront Ecological Environment Treatment Co Ltd
SHG:605069
|
-0.050x |
|
Orbit Technologies Ltd
TA:ORBI
|
-0.056x |
Annual Cash Flow Conversion Efficiency for Jilin Jian Yisheng Pharmaceutical Co Ltd (2006–2025)
The table below shows the annual cash flow conversion efficiency of Jilin Jian Yisheng Pharmaceutical Co Ltd from 2006 to 2025. Also see Jilin Jian Yisheng Pharmaceutical Co Ltd assets under control for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.33 Billion ≈ $340.85 Million |
CN¥98.74 Million ≈ $14.45 Million |
0.042x | +67.81% |
| 2024-12-31 | CN¥2.33 Billion ≈ $341.45 Million |
CN¥58.94 Million ≈ $8.63 Million |
0.025x | -71.83% |
| 2023-12-31 | CN¥2.33 Billion ≈ $341.31 Million |
CN¥209.13 Million ≈ $30.60 Million |
0.090x | +38.28% |
| 2022-12-31 | CN¥2.25 Billion ≈ $329.16 Million |
CN¥145.86 Million ≈ $21.34 Million |
0.065x | -33.73% |
| 2021-12-31 | CN¥2.20 Billion ≈ $321.68 Million |
CN¥215.10 Million ≈ $31.48 Million |
0.098x | +2.52% |
| 2020-12-31 | CN¥2.13 Billion ≈ $312.01 Million |
CN¥203.51 Million ≈ $29.78 Million |
0.095x | -6.86% |
| 2019-12-31 | CN¥2.06 Billion ≈ $301.13 Million |
CN¥210.87 Million ≈ $30.86 Million |
0.102x | +20.38% |
| 2018-12-31 | CN¥1.97 Billion ≈ $287.63 Million |
CN¥167.32 Million ≈ $24.48 Million |
0.085x | -40.34% |
| 2017-12-31 | CN¥1.90 Billion ≈ $277.60 Million |
CN¥270.65 Million ≈ $39.61 Million |
0.143x | +1566.43% |
| 2016-12-31 | CN¥1.80 Billion ≈ $263.55 Million |
CN¥-17.52 Million ≈ $-2.56 Million |
-0.010x | +94.76% |
| 2015-12-31 | CN¥1.75 Billion ≈ $255.36 Million |
CN¥-324.29 Million ≈ $-47.45 Million |
-0.186x | +45.04% |
| 2014-12-31 | CN¥1.75 Billion ≈ $256.24 Million |
CN¥-592.06 Million ≈ $-86.64 Million |
-0.338x | -200.85% |
| 2013-12-31 | CN¥1.68 Billion ≈ $245.38 Million |
CN¥-188.45 Million ≈ $-27.58 Million |
-0.112x | -325.88% |
| 2012-12-31 | CN¥1.59 Billion ≈ $232.57 Million |
CN¥79.08 Million ≈ $11.57 Million |
0.050x | +167.19% |
| 2011-12-31 | CN¥1.51 Billion ≈ $221.56 Million |
CN¥-112.12 Million ≈ $-16.41 Million |
-0.074x | -152.47% |
| 2010-12-31 | CN¥359.40 Million ≈ $52.59 Million |
CN¥50.73 Million ≈ $7.42 Million |
0.141x | -68.34% |
| 2009-12-31 | CN¥280.99 Million ≈ $41.12 Million |
CN¥125.25 Million ≈ $18.33 Million |
0.446x | +378.16% |
| 2008-12-31 | CN¥219.89 Million ≈ $32.18 Million |
CN¥20.50 Million ≈ $3.00 Million |
0.093x | -76.82% |
| 2007-12-31 | CN¥205.59 Million ≈ $30.08 Million |
CN¥82.66 Million ≈ $12.10 Million |
0.402x | +275.13% |
| 2006-12-31 | CN¥238.69 Million ≈ $34.93 Million |
CN¥25.58 Million ≈ $3.74 Million |
0.107x | -- |
About Jilin Jian Yisheng Pharmaceutical Co Ltd
Jilin Jian Yisheng Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, wholesale, retail, import, and export of pharmaceutical products in China. The company offers paper packaging products; drugs comprising capsules, injections, tablets, granules, and other drug products; cosmetics; ginseng products; bee products; and food products comprisi… Read more